Release Date: 15/09/14 10:17 Summary: Target's Statement in relation to the MetroCoal offer Price Sensitive: Yes Download Document 3.5MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%